ID   MCF-7(DOX/R)
AC   CVCL_C4M9
SY   MCF-7 (DOX/R)
DR   Wikidata; Q116049775
RX   PubMed=15273662;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=15273662;
RA   Chorna I., Bilyy R., Datsyuk L., Stoika R.;
RT   "Comparative study of human breast carcinoma MCF-7 cells differing in
RT   their resistance to doxorubicin: effect of ionizing radiation on
RT   apoptosis and TGF-beta production.";
RL   Exp. Oncol. 26:111-117(2004).
//